{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-115596","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.964662+00:00","generated_at":"2026-05-30T12:49:17.633206+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"MiNK Therapeutics CSO Marc Van Dijk transitions to advisory roles effective Nov 15","bullets":["Dr. Marc Van Dijk leaves Chief Scientific Officer role, becomes Scientific Advisory Board Member and Strategic Consultant.","Transition effective November 15, 2024; Van Dijk to continue supporting programs and collaborations.","No replacement for CSO announced; advisory roles indicate retained expertise."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-115596","json":"https://secwatch.observer/filing/0000950170-24-115596.json","markdown":"https://secwatch.observer/filing/0000950170-24-115596.md","text":"https://secwatch.observer/filing/0000950170-24-115596.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024115596/0000950170-24-115596-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024115596/inkt-20241015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:49:17.633206+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89eb605ee0","claim":"Dr. Marc Van Dijk changed role as Chief Scientific Officer at MiNK Therapeutics, Inc..","evidence_excerpt":"Dr. Marc Van Dijk will transition from his role as Chief Scientific Officer and assume the positions of Scientific Advisory Board Member and Strategic Consultant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024115596/0000950170-24-115596-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned from"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}